These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3958772)

  • 21. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
    Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
    Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
    Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.
    Vriesendorp HM; Herpst JM; Germack MA; Klein JL; Leichner PK; Loudenslager DM; Order SE
    J Clin Oncol; 1991 Jun; 9(6):918-28. PubMed ID: 2033428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of iron dextran on ferritin content and 131I-antiferritin localization in experimental hepatomas.
    Rostock RA; Kopher KA; Bauer TW; Klein JL
    Cancer Drug Deliv; 1985; 2(1):3-9. PubMed ID: 3902193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of isotopic immunoglobulin in therapy.
    Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
    Cancer Res; 1980 Aug; 40(8 Pt 2):3001-7. PubMed ID: 6249495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
    Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferritin concentration and 131I-antiferritin tumor localization in an experimental hepatoma.
    Klein JL; Kopher KA; Rostock RA
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):137-40. PubMed ID: 3943985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease.
    Lenhard RE; Order SE; Spunberg JJ; Asbell SO; Leibel SA
    J Clin Oncol; 1985 Oct; 3(10):1296-300. PubMed ID: 4045523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodination of antiferritin by the method of Bolton and Hunter.
    Gonyea-Stewart L
    Clin Chem; 1981 Apr; 27(4):643. PubMed ID: 7471447
    [No Abstract]   [Full Text] [Related]  

  • 30. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 31. Illusions of tumour killing using radiolabelled antibodies.
    Vaughan AT; Bradwell AR; Dykes PW; Anderson P
    Lancet; 1986 Jun; 1(8496):1492-3. PubMed ID: 2873294
    [No Abstract]   [Full Text] [Related]  

  • 32. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease.
    Vriesendorp HM; Morton JD; Quadri SM
    Cancer Res; 1995 Dec; 55(23 Suppl):5888s-5892s. PubMed ID: 7493365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Targeting study of human hepatocellular carcinoma (HCC) using human HCC model in nude mice].
    Liu KD
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):414-6. PubMed ID: 2855054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new method for delivering radioactive cytotoxic agents in solid cancers.
    Order SE; Siegel JA; Lustig RA; Principato R; Zeiger LS; Johnson E; Zhang H; Lang P; Pilchik NB; Metz J
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):715-20. PubMed ID: 7928505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic applications of radiolabelled antibodies: current situation and prospects.
    Larson SM; Carrasquillo JA; Reynolds JC; Hellstrom I; Hellstrom KE; Mulshine JC; Mattis LE
    Int J Rad Appl Instrum B; 1986; 13(2):207-13. PubMed ID: 3490462
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors that affect antiferritin localization in four rat hepatoma models.
    Rostock RA; Kopher KA; Bauer TW; Klein JL
    Cancer Drug Deliv; 1985; 2(2):139-45. PubMed ID: 3902194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
    Rai R; Rai S
    Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
    [No Abstract]   [Full Text] [Related]  

  • 39. [Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies--initial results of a clinical study].
    Müller-Gärtner HW; Montz R; Klapdor R; Hirschmann M; Rehpenning W; Langkowski J
    Nuklearmedizin; 1988 Dec; 27(6):258-65. PubMed ID: 3217256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of 131I-labeled antibodies in human renal cell carcinomas and in a mouse hepatoma and correlation with tumor detection by photoscanning.
    Ghose T; Norvell ST; Aquino J; Belitsky P; Tai J; Guclu A; Blair AH
    Cancer Res; 1980 Aug; 40(8 Pt 2):3018-31. PubMed ID: 7397696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.